Furanocoumarins as Enhancers of Antitumor Potential of Sorafenib and LY294002 toward Human Glioma Cells In Vitro

Joanna Sumorek-Wiadro,Adrian Zając,Krystyna Skalicka-Woźniak,Wojciech Rzeski,Joanna Jakubowicz-Gil

DOI: https://doi.org/10.3390/ijms25020759

IF: 5.6

2024-01-08

International Journal of Molecular Sciences

Abstract:Furanocoumarins are naturally occurring compounds in the plant world, characterized by low molecular weight, simple chemical structure, and high solubility in most organic solvents. Additionally, they have a broad spectrum of activity, and their properties depend on the location and type of attached substituents. Therefore, the aim of our study was to investigate the anticancer activity of furanocoumarins (imperatorin, isoimperatorin, bergapten, and xanthotoxin) in relation to human glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cell lines. The tested compounds were used for the first time in combination with LY294002 (PI3K inhibitor) and sorafenib (Raf inhibitor). Apoptosis, autophagy, and necrosis were identified microscopically after straining with Hoechst 33342, acridine orange, and propidium iodide, respectively. The levels of caspase 3 and Beclin 1 were estimated by immunoblotting and for the blocking of Raf and PI3K kinases, the transfection with specific siRNA was used. The scratch test was used to assess the migration potential of glioma cells. Our studies showed that the anticancer activity of furanocoumarins strictly depended on the presence, type, and location of substituents. The obtained results suggest that achieving higher pro-apoptotic activity is determined by the presence of an isoprenyl moiety at the C8 position of the coumarin skeleton. In both anaplastic astrocytoma and glioblastoma, imperatorin was the most effective in induction apoptosis. Furthermore, the usage of imperatorin, alone and in combination with sorafenib or LY294002, decreased the migratory potential of MOGGCCM and T98G cells.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper aims to explore furanocoumarins (imperatorin, isoimperatorin, bergapten, and xanthotoxin) as anti - tumor adjuvants to enhance the anti - tumor potential of sorafenib (a Raf kinase inhibitor) and LY294002 (a PI3K kinase inhibitor) in human glioma cell lines (T98G and MOGGCCM).

Specifically, the researchers hope to verify the following points through experiments:
1. **Furanocoumarins used alone**: Evaluate the effects of these compounds on glioma cell apoptosis, autophagy and necrosis at different concentrations.
2. **Combined with sorafenib or LY294002**: Investigate whether these compounds can enhance the anti - tumor effects of these two drugs, especially their role in inducing apoptosis.
3. **Molecular mechanisms**: Explore the mechanism of action of these compounds in the cell death process by detecting the levels of Beclin 1 and caspase 3, as well as the activity of caspase 3.

The research results show that imperatorin has the most significant effect on inducing apoptosis of glioma cells when used alone and in combination with sorafenib or LY294002. In addition, imperatorin can also reduce the migration ability of glioma cells, further enhancing its anti - tumor effect.